La Marató TV3 funds two IDIBELL research projects
199.715,36€ 399.995,53 €
La Marató TV3 funds two IDIBELL research projects Read More »
Difficult treatment Resistence biomarkers Article reference
Useful markers to predict response to chemotherapy in patients with liver cancer Read More »
On September 3 Alexandre Puerto joined as the new IDIBELL Management Director. Mr. Puerto joins IDIBELL after being part of the IRB Barcelona, where he has directed for more than six years the Department of Finance and management and project justification. Previously, he has developed his career in multinationals in different sectors in Spain and
Alexandre Puerto, new IDIBELL Management Director Read More »
Award Ceremony of the XI Call for Research Grants of the Mutua Madrileña Foundation attended by Secretary of State for Research, Development and Innovation, Carmen Vela was held last October 10. The team leader of the ICO-IDIBELL chemoresistance research group, Alberto Villanueva, has received 41,000 euros to finance a project aimed at personalizing lung cancer.
Manel Esteller, Director of the Cancer Epigenetics and Biology Program (PEBC) at IDIBELL, Professor of Genetics at the University of Barcelona and ICREA Research Professor, has been elected as member of the European Academy of Cancer Sciences (EACS). The European Academy of Cancer Sciences (EACS) was launched in September 2009 at the ECCO 15:34th ESMO
Manel Esteller, elected as member of the European Academy of Cancer Sciences Read More »
Paz Fernández has been nearly thirty years devoted to cancer nursing. Shes tarted in 1984 at the Plato Polyclinic Institute and in 1991 she was incorporated into the Hospital Duran i Reynals where oncology services at University Hospital of Bellvitge were before the creation of the ICO of the year 1995. Since 2001 she is
Paz Fernández, Award for Lifetime Achievement by the EONS Read More »
Recognition of a career Molla d’or Award
Jaume Reventós, Molla d’or Award 2014 Read More »